EyeD Pharma is a pharmaceutical company dedicated to the development of innovative drug products in ophthalmology.
We also distribute surgical products to ophthalmologists who need the highest quality of products for their clinical practice.
EyeD Pharma is born to the combination of the clinical expertise of Prof. Jean-Marie Rakic and the entrepreneurial experience and polymer expertise of Prof Jean-Michel Foidart, Melanie Mestdagt and Marc Foidart.
EyeD Pharma was founded to answer to unmet clinical needs in ophthalmology by offering patients intra-ocular implants able to release drugs in a very precisely controlled way for several years to remove compliance issue and avoid degradation of the pathology.
EyeD Pharma becomes exclusive distributor of Bausch & Lomb‘s surgical products in Belgium and Luxembourg.
EyeD Pharma aims to become a leader in the development, production and commercialization of micro-implants ensuring a controlled release of drugs in Ophthalmology to find solutions to unmet medical needs in ocular pathologies.
EyeD Pharma’s unique value proposal relies on a fully integrated approach with a technological platform and expertises allowing the development from idea to market authorization, including manufacturing.
Our product candidates are based on innovative drug delivery system, well known API’s and based on medical unmet need advised by internationally renowned key opinion leaders. Our innovative drug products are designed to ensure a full compliance of the patient while drastically reducing or even eliminating side-effects and avoiding degradation of the pathology.
Our technological platform allows several applications outside of our internal focus on ophthalmology. This includes treatments to be addressed locally in very small parts of the human body (like ear-throat-nose, oncology, neurology…), on a stand-alone basis or through dedicated partnerships.
EyeD Pharma manages the entire development process from the idea to the market including product development, non-clinical & clinical studies. Our development, clinical and commercial batches are produced on our internally developed specific production process.
EyeD Pharma has a multidisciplinary team combining advanced expertise in chemistry, industrial process, pharmaceutical development, controlled release, regulatory affairs, preclinical, clinical, financial and business fields.
Our sales department also has a strong expertise (more than 20 years) in ophthalmic surgery.
Our managers have an average experience
Team GrowthAll our product candidates aim to enhance patient quality of life and are based on clinical unmet need identified by internationally renowned KOL’s
We manage all the expertise and processes, from the idea to the market
Creation of high-quality long-term employment and significant contribution to the economic redeployment of Wallonia. Eyed’s team is today composed of 66 FTEs
Our technological platform allows to give access to long term innovative ophthalmological treatments to developing countries populations, where glaucoma is the second cause of blindness
